Article
Mutations in THAP11 cause an inborn error of cobalamin metabolism and developmental abnormalities.
Human molecular genetics - 1 Aug 2017
Quintana Anita M, Yu Hung-Chun, Brebner Alison, Pupavac Mihaela, Geiger Elizabeth A, Watson Abigail, Castro Victoria L, Cheung Warren, Chen Shu-Huang, Watkins David, Pastinen Tomi, Skovby Flemming, Appel Bruce, Rosenblatt David S, Shaikh Tamim H
Abstract excerpt
CblX (MIM309541) is an X-linked recessive disorder characterized by defects in cobalamin (vitamin B12) metabolism and other developmental defects. Mutations in HCFC1, a transcriptional co-regulator which interacts with multiple transcription factors, have been associated with cblX. HCFC1 regulates cobalamin metabolism via the regulation of MMACHC expression through its interaction with THAP11, a THAP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
